AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for “Bubble Baby Disease”
Collaboration will leverage AGC Biologics’ commercial manufacturing experience and proven platforms to seek regulatory approval for a therapy treating the rare immunodeficiency disorder, ADA-SCID